Israel’s BrainStorm Offers Encouraging Phase 2 Data on Stem-Cell Therapy NurOwn to Treat ALS – ALS News Today
ALS News Today |
Israel's BrainStorm Offers Encouraging Phase 2 Data on Stem–Cell Therapy NurOwn to Treat ALS
ALS News Today Israel's BrainStorm Cell Therapeutics has announced positive top-line Phase 2 data on NurOwn, a customized stem–cell therapy technology to treat amyotrophic lateral sclerosis (ALS). BrainStorm has been developing and commercializing NurOwn in … |
